Biodistribution studies
Preclinical biodistribution studies to evaluate how therapeutic agents distribute and accumulate across tissues and organs in vivo.
Preclinical biodistribution overview
Biodistribution studies characterize how therapeutic agents distribute and accumulate across tissues and organs following administration. At IVRS, we provide preclinical in vivo biodistribution studies to quantify tissue distribution and target-site accumulation, generating robust data to support drug development decisions.
IVRS provides tailored preclinical biodistribution studies designed around your therapeutic agent, route of administration and study objectives. Our approach generates quantitative in vivo distribution data to support informed drug development decisions.
In vivo tracking
Track therapeutic agent distribution using advanced imaging approaches to generate quantitative biodistribution data.
Tissue & organ analysis
Quantify therapeutic agent accumulation in relevant tissues and organs.
Quantitative biodistribution
Generate quantitative distribution data to support dose, administration route and formulation decisions.
Tailored study design
Customize biodistribution studies to the therapeutic agent, administration route and specific development objectives.
Key capabilities
- In vivo tracking & imaging
- Tissue & organ analysis
- Quantitative biodistribution
- Tailored study design
In vivo research services
Preclinical in vivo capabilities
01
In vivo imaging
Advanced in vivo imaging for longitudinal monitoring of disease progression and treatment response.
Read more →
02
Drug validation
Preclinical drug validation to assess therapeutic potential, biological activity and treatment response.
Read more →
03
Drug efficacy
In vivo drug efficacy studies to evaluate therapeutic response, dose effects and treatment outcomes.
Read more →
04
Biodistribution studies
Biodistribution studies to track drug delivery, tissue distribution and target-specific accumulation in vivo.
Read more →
05
Toxicology assessment
Preclinical toxicology studies to evaluate drug safety, tolerability and potential adverse effects.
Read more →
06
Preclinical study design
Customized preclinical study design tailored to disease models, therapeutic targets and drug development goals.
Read more →
Engage with us for journey to success
Do you want to learn more about our work and how we can help you?